| IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling PC Maity, M Bilal, MT Koning, M Young, CAM van Bergen, V Renna, ... Proceedings of the National Academy of Sciences 117 (8), 4320-4327, 2020 | 73 | 2020 |
| MYD88 in the driver’s seat of B-cell lymphomagenesis: From molecular mechanisms to clinical implications RAL de Groen, AMR Schrader, MJ Kersten, ST Pals, JSP Vermaat haematologica 104 (12), 2337, 2019 | 66 | 2019 |
| MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis JS Vermaat, SF Somers, LC de Wreede, W Kraan, RAL de Groen, ... Haematologica 105 (2), 424, 2020 | 64 | 2020 |
| Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing W Arindrarto, DM Borràs, RAL de Groen, RR van den Berg, IJ Locher, ... Leukemia 35 (1), 47-61, 2021 | 63 | 2021 |
| Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype RAL de Groen, R van Eijk, S Böhringer, T van Wezel, R Raghoo, D Ruano, ... Blood advances 5 (19), 3760-3775, 2021 | 21 | 2021 |
| High frequency of inactivating tetraspanin CD37 mutations in diffuse large B-cell lymphoma at immune-privileged sites S Elfrink, CM de Winde, M van den Brand, M Berendsen, MGM Roemer, ... Blood, The Journal of the American Society of Hematology 134 (12), 946-950, 2019 | 19 | 2019 |
| Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas AMR Schrader, RAL de Groen, R Willemze, PM Jansen, KD Quint, ... Virchows Archiv, 1-9, 2022 | 14 | 2022 |
| Biological and clinical implications of gene-expression profiling in diffuse large B-cell lymphoma: a proposal for a targeted BLYM-777 consortium panel as part of a … FA de Groot, RAL de Groen, A van den Berg, PM Jansen, KH Lam, ... Cancers 14 (8), 1857, 2022 | 9 | 2022 |
| BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis AA Acosta-Medina, PG Kemps, TCE Zondag, JP Abeykoon, J Forma-Borst, ... Blood 142 (18), 1570-1575, 2023 | 7 | 2023 |
| Autonomous B-cell receptor signaling and genetic aberrations in chronic lymphocytic leukemia-phenotype monoclonal B lymphocytosis in siblings of patients with chronic … E Quinten, JH Sepúlveda-Yáñez, MT Koning, JA Eken, D Pfeifer, ... Haematologica 109 (3), 824, 2024 | 4 | 2024 |
| Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas LM de Haan, RAL de Groen, FA de Groot, T Noordenbos, T van Wezel, ... Virchows Archiv, 1-12, 2023 | 3 | 2023 |
| Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for … AMR Schrader, RAL de Groen, R Willemze, PM Jansen, KD Quint, ... Cancers 14 (20), 5152, 2022 | 3 | 2022 |
| High-throughput bcr sequencing and single-cell transcriptomics reveal distinct transcriptional profiles associated with subclonal evolution of follicular lymphoma CAM van Bergen, MT Koning, E Quinten, A Mykowiecka, J Sepulveda, ... Blood 134, 298, 2019 | 3 | 2019 |
| Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen FA De Groot, JK Doorduijn, M Brink, RAL De Groen, LM De Haan, ... Blood 140 (Supplement 1), 369-371, 2022 | 2 | 2022 |
| Synchronous diffuse large B-cell lymphoma and mantle cell lymphoma: support for low-threshold biopsies and genetic testing FA de Groot, LM de Haan, RAL de Groen, L Heijmen, T van Wezel, ... Leukemia & lymphoma 63 (5), 1251-1255, 2022 | 2 | 2022 |
| Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL JA Eken, MT Koning, K Kupcova, JH Sepúlveda Yáñez, RAL de Groen, ... Journal of Experimental Medicine 221 (5), 2024 | 1 | 2024 |
| Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features PRG Eriksen, F de Groot, E Clasen-Linde, P de Nully Brown, R de Groen, ... Blood advances, 2024 | 1 | 2024 |
| A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma DAG van Bladel, WBC Stevens, LI Kroeze, RAL de Groen, FA de Groot, ... Blood Advances 7 (19), 5911-5924, 2023 | 1 | 2023 |
| Special anatomical subtypes of diffuse large B-cell lymphoma have distinct tumor microenvironments T Noordenbos, FA De Groot, RAL De Groen, LM De Haan, RT Krog, ... Blood 140 (Supplement 1), 164-165, 2022 | 1 | 2022 |
| Autonomous BCR signaling and genetic aberrations in CLL-phenotype monoclonal B lymphocytosis in siblings of CLL patients JH Sepulveda Yanez, E Quinten, MT Koning, JA Eken, D Pfeifer, ... Blood 140 (Supplement 1), 1526-1527, 2022 | 1 | 2022 |
